DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DesignMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10591
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that provides cure for drug-resistant malaria to vulnerable patients including children and pregnant women. DesignMedix’s DM1157 product overcomes drug resistance in blood samples from patients infected with drug-resistant malaria parasites. The company’s malaria preventive drugs provide novel therapeutic agents that are used in prevention of liver-stage malaria in a mouse model. DesignMedix is headquartered in Portland, Oregon, the US.

DesignMedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DesignMedix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
DesignMedix Raises USD0.7 Million in Venture Financing 10
DesignMedix Raises USD1.5 Million in Venture Financing 11
DesignMedix Raises USD0.53 Million in Venture Financing 12
Partnerships 13
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 13
Licensing Agreements 14
DesignMedix Enters into Licensing Agreement with University of California, San Diego 14
DesignMedix Inc – Key Competitors 15
DesignMedix Inc – Key Employees 16
DesignMedix Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
DesignMedix Inc, Pharmaceuticals & Healthcare, Key Facts 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DesignMedix Raises USD0.7 Million in Venture Financing 10
DesignMedix Raises USD1.5 Million in Venture Financing 11
DesignMedix Raises USD0.53 Million in Venture Financing 12
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 13
DesignMedix Enters into Licensing Agreement with University of California, San Diego 14
DesignMedix Inc, Key Competitors 15
DesignMedix Inc, Key Employees 16

List of Figures
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …
  • Archer Daniels Midland Co:企業のM&A・事業提携・投資動向
    Archer Daniels Midland Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archer Daniels Midland Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Hyduke Energy Services Inc (HYD):石油・ガス:M&Aディール及び事業提携情報
    Summary Hyduke Energy Services Inc. (Hyduke) is an integrated oilfield services company that manufacture, repair and distributes oilfield equipment and supplies. It carries out the engineering, design and manufacture of land-based drilling rigs, service rigs, coiled tubing units, pump units, cranes, …
  • Stolt-Nielsen Ltd (SNI)-石油・ガス分野:企業M&A・提携分析
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) formerly Stolt-Nielsen S.A., is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company services include transportation of liquefied petroleum gas (LPG), terminal storage and dist …
  • Carillion plc:戦略・SWOT・企業財務分析
    Carillion plc - Strategy, SWOT and Corporate Finance Report Summary Carillion plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Akcansa Cimento Sanayi ve Ticaret AS:企業の戦略・SWOT・財務情報
    Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Willis Lease Finance Corporation (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corporation (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • General Dynamics Corporation:企業の戦略・SWOT・財務情報
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sanara MedTech Inc (WNDM):企業の財務・戦略的SWOT分析
    Summary Sanara MedTech Inc (Sanara MedTech), formerly WNDM Medical Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its pro …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …
  • Stabilis Solutions Inc (AETI):企業の財務・戦略的SWOT分析
    Summary Stabilis Solutions Inc (Stabilis Solutions) formerly, Stabilis Energy Inc a subsidiary of Amnor Technologies Inc, is a provider of power delivery solutions. The company's products comprise power distribution and power conversion products. Stabilis Solutions power distribution products compri …
  • Ontario Teachers’ Pension Plan:企業の戦略・SWOT・財務情報
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jardine Matheson Holdings Ltd
    Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Grifols SA (GRF)-医療機器分野:企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Strike Resources Ltd (SRK):企業の財務・戦略的SWOT分析
    Summary Strike Resources Ltd (Strike Resources) is a mining and mineral exploration and development company. The company explores for uranium, coal, and iron ore. Strike Resources’ projects portfolio includes Cusco Iron Ore project, Burke Graphite Project, Solaroz Lithium Brine Project, Pilbara Lith …
  • ICF International, Inc.:企業の戦略・SWOT・財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • Proofpoint Inc (PFPT):企業の財務・戦略的SWOT分析
    Proofpoint Inc (PFPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務分析
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆